<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="../../web/xslt/drug-table.xslt"?><drug name = "streptozocin inj VIAL">
<dose><value>500</value>
</dose><route><value>IV</value>
</route><form><value>inj VIAL</value>
</form><drugname><value>streptozocin inj VIAL</value>
</drugname><strength><value>1 g</value>
</strength><frequency><value>DAILY</value>
</frequency><instruction><value>for 5 days. Dilute dose in 500 mL 0.9%25 sodium chloride and administer over 1 hour.</value>
<value>for 5 days. Dilute dose in 100 mL 0.9%25 sodium chloride and administer over 30 minutes.</value>
</instruction><volume></volume><units><value>mg/m2</value>
</units><additionalnotes><value>Metastatic Carcinoid Tumour. Suggested Maximum single dose: 1500 mg/m2. Adjust dose for renal function: CrCl of 10 to 50 mL/minute, 75%25 of dose, CrCl less than 10 mL/minute: 50%25 of dose.</value>
<value>Endocrine Tumour. Suggested Maximum single dose: 1500 mg/m2. Adjust dose for renal function: CrCl of 10 to 50 mL/minute, 75%25 of dose, CrCl less than 10 mL/minute: 50%25 of dose.</value>
</additionalnotes><population><value>ADULT</value>
</population><indicationprn></indicationprn><backgroundinformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=3442</value>
</backgroundinformation><prninformation></prninformation><ahsformularystatus><value>Formulary, Health Canada Special Access Programme.</value>
</ahsformularystatus><ahfsname><value>Antineoplastic Agents</value>
</ahfsname><highalert><value>YES</value>
</highalert><maximumprndose></maximumprndose><din><value>0703-4636</value>
</din><type><value>Medication/IV Therapy</value>
</type></drug>